Is this you?
Request access for Nephrology Associates PA with your @unknown work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
Nephrology Associates PA
Unclaimed profileSite Network · Newark, Delaware · ~13 sites
Intera lens
ICP 6Lift (cardio sample) 0.47Recruit soph 0.14
Quality Scorecard (1–100)
Overall66Recruit51Ops71Sponsor73Ther70
Performance (observed)
Historical trials
209
Completed
121
Terminated/Withdrawn
37
Completion rate
77%
Active now
46
Phase 2
62
Phase 3
114
Realized enrollment
258,581
First study year
2001
Years active
25
Match confidence
high
Enrollment velocity (inf)
10,343
Therapeutic
Areas
Kidney diseases, chronic renal insufficiency, IgA glomerulonephritis, chronic kidney failure
Breadth (conditions)
180
States
Delaware, Mississippi, Rhode Island
Recruitment (web observed)
Advertises recruitment
Yes
Capability notes
High - part of Frenova Renal Research with access to 2M+ patient longitudinal database via Fresenius
Relationships
Sponsors
Boehringer Ingelheim; Pfizer; Bayer; Eli Lilly and Company; Vertex Pharmaceuticals Incorporated; Novartis Pharmaceuticals
CROs
Medpace, Inc.; MicroConstants; Worldwide Clinical Trials
Owner / parent
Frenova Renal Research (subsidiary of Fresenius Medical Care)
Capacity & people
Investigators
—
Coordinators
—
CEO
Unknown (Site-level: Brianna Atkinson - Site Operations Contact for Delaware)
VP Clinical Ops
Unknown
VP Site Ops
Brianna Atkinson (Frenova Site Operations)
VP Recruitment
Unknown
Emails
ariley@nakidneydocs.com, Brianna.Atkinson@Frenova.com
Tech & DCT
Builds tech
Vendors (Frenova platform)
Tech stack
Frenova proprietary tools, technology-assisted screening and enrollment
Recruiting visible
Y
Notes
Part of Frenova F1RST UP network focused on renal research. ClinicalTrials.gov validation: 4 active recruiting cardiometabolic trials (secondary cardiometabolic diseases common in renal patients). Access to massive patient database through Fresenius relationship. Limited cardiometabolic primary focus.
Recommendation features (sample indication)
Ind fit 0.55Liftability 0.47Overall66
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.